Amedisys
AMED
#3440
Rank
$3.14 B
Marketcap
$96.13
Share price
1.80%
Change (1 day)
21.48%
Change (1 year)
Amedisys Home Health and Hospice Care, is an American home health provider.

P/E ratio for Amedisys (AMED)

P/E ratio as of May 2024 (TTM): 961

According to Amedisys's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 961.3. At the end of 2022 the company had a P/E ratio of 22.9.

P/E ratio history for Amedisys from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202222.9-9.51%
202125.3-51.45%
202052.123.29%
201942.331.71%
201832.1-45.22%
201758.653.87%
201638.1-110.65%
2015-357-574.98%
201475.3-1663.77%
2013-4.8119.14%
2012-4.04389.82%
2011-0.8246-109.92%
20108.31-14.82%
20099.76-22.81%
200812.6-34.34%
200719.32.66%
200618.8-14.15%
200521.85.23%
200420.817.78%
200317.6-137.94%
2002-46.5-889.84%
20015.88

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
82.4-91.42%๐Ÿ‡บ๐Ÿ‡ธ USA
47.9-95.02%๐Ÿ‡บ๐Ÿ‡ธ USA
34.6-96.40%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.